- Tytuł :
- Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
- Autorzy :
- Źródło :
- Journal of Autism and Developmental Disorders. :1-14
-
Czasopismo naukowe